Search results
OKT3 After Lung Transplantation
… Purpose OKT3 is an immunosuppressive medicine that helps prevent organ …
Last Modified:
HeartMate® III IDE Study
… The HeartMate III Left Ventricular Assist System (LVAS) is a prospective, multi-center, study comparing the HeartMate …
Last Modified:
Antibiotic Medications After Lung Transplantation
… Purpose Prevents bacterial infections. Dosage Bactrim is available in pill form and adults will take one tablet …
Last Modified:
Weight Loss Surgery Newsletter February 2017
… Now Die from Diabetes NBC News: Weight Loss Surgery is Most Effective Treatment for Diabetes Weight Loss Surgery …
Last Modified:
Weight Loss Surgery Newsletter September 2018
… Do You Quality for Bariatric Surgery? Weight-Loss Surgery is Cost Effective Sign Up for Email Newsletters » …
Last Modified:
Jean C. Emond, MD
… Dr. Emond is the Vice Chairman of Surgery at Columbia University. He … and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant …
Last Modified:
OKT3® (Monoclonal Antibody)
… Purpose OKT3 is an immunosuppressive medicine that helps prevent organ …
Last Modified:
Antiviral Medications
… the first 3 months, after transplant. Valcyte adult dosage is typically 900mg taken once a day for 3 months to one year …
Last Modified:
Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH
… to Non-Alcoholic Steatohepatitis (NASH) This study is to evaluate the safety and efficacy of simtuzumab …
Last Modified:
Post-Approval Study Of Transcarotid Artery Revascularization In Patients With Significant Carotid Artery Disease
… Study Overview The ROADSTER 2 Study is an open label, single arm, multi-center post-approval …
Last Modified:
Weight Loss Surgery Newsletter June 2018
… AND Marriages after Bariatric Surgery Weight-Loss Surgery is Cost Effective Sign Up for Email Newsletters » …
Last Modified:
Xiaowei Chen, MD
… Dr. Xiaowei Chen is a board certified pathologist who specializes in …
Last Modified:
Prospective Randomized Double Blind Placebo Controlled Trial of Rifaximin 550mg PO Twice Daily for Three Months to Prevent Recurrent Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C Virus Infection
… The purpose of this study is to determine if the administration of a poorly-absorbable …
Last Modified:
General Surgery Presentations and Research
… This quarterly report is a summary of the monthly Faculty Research Newsletter. …
Last Modified: